scholarly article | Q13442814 |
P2093 | author name string | Binoy Shivanna | |
Lihua Wang | |||
Shaojie Zhang | |||
Bhagavatula Moorthy | |||
Weiwu Jiang | |||
Ananddeep Patel | |||
Stephen E Welty | |||
P2860 | cites work | Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo | Q24314469 |
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress | Q28264602 | ||
Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor | Q28281351 | ||
Measurement of lipid peroxidation | Q28282293 | ||
Trends in neonatal morbidity and mortality for very low birthweight infants | Q28288675 | ||
Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization | Q28571824 | ||
Developmental changes in the expression of enterocytic and hepatic cytochromes P4501A in rat | Q28581265 | ||
Induction of cytochrome P4501A1. | Q33636653 | ||
The new BPD: an arrest of lung development | Q33789641 | ||
Hyperoxia-derived lung damage in preterm infants | Q34020504 | ||
Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. | Q34493101 | ||
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities | Q34549376 | ||
Bronchopulmonary dysplasia-oxidative stress and antioxidants | Q35095604 | ||
Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes | Q35265520 | ||
Prenatal administration of the cytochrome P4501A inducer, Β-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants | Q35381595 | ||
Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: Mechanistic roles of antioxidant enzymes and RelB | Q35690492 | ||
Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. | Q35781348 | ||
Nuclear receptors and drug disposition gene regulation | Q36109707 | ||
The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth | Q36122596 | ||
Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease | Q36330521 | ||
Functional deficiency of aryl hydrocarbon receptor augments oxygen toxicity-induced alveolar simplification in newborn mice | Q36640051 | ||
Mechanisms of cytochrome P450 induction | Q36971478 | ||
Cyclooxygenase-2 in newborn hyperoxic lung injury | Q37117181 | ||
Molecular mechanisms of quinone cytotoxicity | Q37367251 | ||
Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor | Q37514105 | ||
Oxygen and oxidative stress in bronchopulmonary dysplasia | Q37784210 | ||
The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. | Q39951464 | ||
Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements | Q40566958 | ||
Delayed ontogenesis of CYP1A2 in the human liver | Q41061622 | ||
The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. | Q41482544 | ||
Ah receptor, a novel ligand-activated transcription factor | Q41719577 | ||
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man | Q41950324 | ||
Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats | Q42166833 | ||
Rat parietal cell function after prolonged inhibition of gastric acid secretion | Q42501306 | ||
Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants | Q42623620 | ||
A peroxynitrite decomposition catalyst prevents 60% O2-mediated rat chronic neonatal lung injury | Q42963828 | ||
Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245 | Q43221245 | ||
The pleiotropy of dioxin toxicity--xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles. | Q43271208 | ||
Role of NRF2 in protection against hyperoxic lung injury in mice | Q43862673 | ||
Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. | Q43863401 | ||
Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung | Q43889972 | ||
Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. | Q44491300 | ||
Altered pharmacokinetics of omeprazole in cystic fibrosis knockout mice relative to wild-type mice. | Q45023482 | ||
Vascular endothelial growth factor receptor 2 blockade disrupts postnatal lung development | Q45275873 | ||
Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury | Q47657034 | ||
Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species | Q47774945 | ||
Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen. | Q51974340 | ||
Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. | Q52205520 | ||
A low vitamin A status increases the susceptibility to cigarette smoke-induced lung emphysema in C57BL/6J mice. | Q53240654 | ||
BALT development and augmentation of hyperoxic lung injury in mice deficient in NQO1 and NQO2. | Q54603321 | ||
Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicity | Q68392488 | ||
Alveolar macrophage status in bronchopulmonary dysplasia | Q68422231 | ||
Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human | Q70806289 | ||
Inhibition of gastric acid secretion by omeprazole in the dog and rat | Q71825761 | ||
Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung | Q73100383 | ||
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions | Q73782168 | ||
Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia | Q74791408 | ||
Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice | Q85888494 | ||
P433 | issue | 1 | |
P921 | main subject | omeprazole | Q422210 |
pulmonary injury | Q7259546 | ||
P304 | page(s) | 276-287 | |
P577 | publication date | 2015-08-13 | |
P1433 | published in | Toxicological Sciences | Q2446966 |
P1476 | title | Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice | |
P478 | volume | 148 |
Q37593878 | Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats |
Q55128096 | Hyperoxia Disrupts Extracellular Signal-Regulated Kinases 1/2-Induced Angiogenesis in the Developing Lungs. |
Q100559648 | Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung |
Q51136732 | Newborn Mice Lacking the Gene for Cyp1a1 Are More Susceptible to Oxygen-Mediated Lung Injury, and Are Rescued by Postnatal β-Naphthoflavone Administration: Implications for Bronchopulmonary Dysplasia in Premature Infants. |
Q36462134 | Omeprazole does not Potentiate Acute Oxygen Toxicity in Fetal Human Pulmonary Microvascular Endothelial Cells Exposed to Hyperoxia |
Q92063898 | Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer |
Q37109084 | Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disea |
Q37212073 | Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury. |
Q47755595 | Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia |
Q40976331 | Sex-specific differences in neonatal hyperoxic lung injury |
Q92644879 | Spatial and temporal expression of SP-B and TGF-β1 in hyperoxia-induced neonatal rat lung injury |
Q33711647 | The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. |
Search more.